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Nuclear magnetic resonance (NMR)
spectroscopy uses the magnetic spin
properties of atomic nuclei within a
molecule to identify atoms that are
close together in space (either
because they are bonded together or
because folds of a protein chain bring
them together). This information is
used to derive a three-dimensional
model of a protein in solution (a
‘solution structure’).
Only certain isotopes, such as 1H,
13C, 15N or 31P, have a magnetic spin;
isotopes such as 12C or 16O are NMR
inactive. Protein samples are now
routinely enriched with 13C and 15N
isotopes to simplify the NMR data
by making it possible to identify
particular isotopes and chemical
groups. During NMR spectroscopy,
protein molecules in solution are
placed in a magnetic field, so that the
magnetic moments of individual
nuclei can align with the field. When
the sample is irradiated with pulses
of radio frequency electromagnetic
radiation, NMR-active nuclei will
resonate at characteristic frequencies.
These different frequencies are
obtained as NMR peaks — relative
to a reference signal — and are called
chemical shifts. The chemical shift
of an atomic nucleus depends on its
molecular environment and is
different for each atom in a protein
molecule, unless two atoms are
magnetically equivalent. For
example, protons within individual
side chain CH3 groups of valine are
magnetically equivalent but the
protons of adjacent side chain CH3
groups of valine are not, because of
their stereochemical positioning.
Multi-dimensional NMR
The standard NMR spectrum of
absorption versus frequency (or
chemical shift) is a one-dimensional
spectrum. In principle, this should
give a unique peak for each NMR-
active nucleus in a molecule but in
practice the peaks often overlap
because of the limited resolving
power of the technique. To
circumnavigate this problem, NMR
is expanded into two or more
dimensions, which enables plots of
correlations between nuclei.
Different types of NMR experiment
display correlations that indicate
whether two nuclei share a ‘through-
bond’ or ‘through-space’
characteristic, in other words,
whether they are bonded together, or
simply on adjacent folds of the
molecule. Two-dimensional NMR
can involve 1H,1H correlations
(known as homonuclear) or, for
isotopically enriched proteins, 1H,13C
or 1H,15N correlations (known as
heteronuclear). Two-dimensional
NMR spectra are displayed as
contour plots with each axis defining
a particular type of nucleus
(Figure 1). Expanding into a third
dimension produces several
combinations including: 1H,1H,13C;
1H,1H,15N; or 1H,13C,15N. A three-
dimensional NMR spectrum is
displayed as slices of two-
dimensional NMR data.
Obtaining a protein structure
Three-dimensional structural
information is obtained primarily
from ‘through-space’ NMR
experiments involving the ‘nuclear
Overhauser effect’ (NOE). The
NOE is a nuclear relaxation effect,
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Figure 1
Two-dimensional 15N,1H HSQC
(heteronuclear single quantum correlation)
NMR spectrum of the inner lipoyl domain from
human pyruvate dehydrogenase multienzyme
complex. Peaks (purple) represent bonds
between the 94 amide nitrogens in the
protein and their protons. The peaks have
subsequently been designated to individual
nuclei within amino acids by the process of
sequential assignment, and are labelled with
the appropriate sequence number and single-
letter amino-acid code.
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the intensity of which is a measure of
the distance between two nuclei that
are close in space in the folded
molecule — even though they may
be quite distant in the primary
sequence of the protein. NOEs are
observed in specific nuclear
Overhauser effect spectroscopy
(NOESY) NMR experiments. The
intensity of NOESY peaks can be
classified as strong (reflecting nuclei
that are less than 3 Å apart in the
molecule), medium (less than 4 Å
apart) and weak (less than 6 Å).
These classifications define the basis
of so-called NOE ‘distance
constraints’.
Although NOESY experiments
provide insights into which amino
acid residues are close in space in the
folded molecule, before the data can
be used each NMR peak must be
assigned to its corresponding amino
acid along the polypeptide chain of
the protein. This is done via the
process of ‘sequential assignment’
which uses specific through-bond
NMR experiments to correlate
nuclei that are connected by one or
many bonds. Sequential assignment
enables the designation of NMR
peaks to individual nuclei within
amino acids and enables the
structural biologist to string adjacent
amino acids residues together in a
sequential fashion. Results from this
stage can be overlaid onto data from
other NMR experiments that
determine the nature of the side
chain for each residue to complete
the assignment strategy.
Once all NOEs are assigned to a
particular amino acid and measured
for intensity, an NOE list is produced
showing all contacts in the molecule.
Structure-calculating programs such
as XPLOR or DYANA take these
NOE data, together with the
sequence for the protein, and attempt
to create a ‘fold’ for the molecule that
satisfies as many of the NOE distance
constraints as possible. Many
programs use a combination of bond,
angle and atomic energy criteria to
define reasonable folds for the
protein. The final structural energy
calculated (energy data), together
with a list of the NOEs that violate
the distance criteria (violations data),
give  an indication of how well the
structure fits the NMR data.
NOE data can be distorted by
spin-diffusion, especially when the
structure of larger molecules is being
determined. In spin-diffusion, the
nuclear relaxation effect is
propagated between two nuclei that
are not necessarily close in space.
This results in NOE contacts being
observed that imply two nuclei are
close in space when, in fact, they are
not. Altering the NMR conditions of
NOESY experiments can give an
indication of the effects of spin-
diffusion on the data.
In addition to NOESY data,
specific NMR experiments can be
used to derive data for dihedral
angles, hydrogen bond donors and
stereospecific nuclei. These data are
used to produce additional
‘constraints’ lists which can be
entered into the structure-calculating
program and so increase the precision
of the final structure. Dihedral angles
are obtained from so-called J coupling
constants, which describe the
hyperfine splitting of an NMR peak
because of the effect on its local
environment of non-equivalent
nuclei that are two, three or four
bonds away.
Hydrogen bond donors are
ascertained from deuterium exchange
experiments, which follow the
exchange of labile protons with time.
The final structure is reached by
analysing violations data and energy
data for each individual structure
calculated from all the constraints
used and modifying the constraints
list so that all violations are satisfied
in subsequent calculations. It may
also be necessary to modify the initial
backbone and side-chain assignments
on the strength of the violations data.
This iterative process takes several
rounds of calculation.
Assessing the quality of structures
Final NMR structures should satisfy
the energy criteria outlined above
and have no violations outside
experimental error for all constraints
used in their calculation. In addition,
all NMR structures are calculated as
an ensemble of structures that are
said to converge on an average point.
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Figure 2
(a) Superposition of 26 conformers and
ribbon representation of the polypeptide fold
of the inner lipoyl domain from human pyruvate
dehydrogenase multienzyme complex (PDHc),
determined by NMR. The structure was
defined from 1136 NOE distance restraints,
43 torsion angle restraints and 25 hydrogen
bond restraints. (b) The derived ribbon model
of the same protein, showing secondary
structure elements.
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Most NMR structure papers display
an ensemble of more than 20
calculated structures, superimposed
so that readers can see well-defined
and poorly defined regions. An
ensemble of 26 structures is shown in
Figure 2a. Poorly defined regions of
the structure aren’t necessarily due
to poor experimental method or data
analysis but can result from loop or
linker regions in a protein that have
very few NOEs defining them.
To quantify these data, the root
mean square deviation (r.m.s.d.) from
the average structure of the ensemble
for backbone and side chain atoms is
calculated. Most structures currently
published have r.m.s.d. values over
the structured regions of less than
0.5 Å, but side chain r.m.s.d. values
are invariably greater (1 Å or more).
The smaller the reported r.m.s.d., the
more precise the structure is. In
addition, there are several computer
packages that assist in determining
the quality of structures by producing
Ramachandran and other plots to
indicate the defined secondary
structure elements and whether they
adhere to rules governing the
orientation and distances of individual
bonds and atoms.
Most publications show a ribbon
model of the structure that clearly
indicates the secondary structure of
the protein (Figure 2b). The ribbon
model can either be the averaged
structure from the r.m.s.d. values or
the structure from the ensemble
which is closest to the r.m.s.d. values.
Finally, it is worth remembering that
any NMR structure is only the result
of the data analysed so, although it
may be precise, it is not necessarily an
accurate representation of the protein
in question, in vivo, for example.
Other uses of NMR
NMR spectroscopy can also be used
to obtain other useful information
about proteins. It is increasingly
common to publish information about
the dynamic motion within proteins
using NMR relaxation data. When an
NMR-active nucleus is detected, this
involves an energy transfer process
(like any spectroscopic technique)
and that nucleus needs to relax back
to its initial state. NMR relaxation
occurs via two major mechanisms,
called spin–lattice and spin–spin
relaxation, which are governed by
rate constants T1 and T2, respectively.
Measurement of these relaxation rate
constants provides information on the
internal motions within the molecule
and can indicate flexible regions that
are of significance to the function of
the protein.
The interactions of proteins with
other molecules (proteins, nucleic
acids, peptides or other ligands) have
also been studied by comparing
chemical shift and relaxation data for a
protein with and without its
interaction component. Those amino
acid residues in contact with the
interacting component will have large
chemical shift or relaxation rate
changes. This enables the definition
of an interacting surface that can be
used to design mutagenesis studies
probing the protein’s function.
Interaction studies by NMR have
been used to advance drug discoveries
by adding libraries of molecules to a
protein and studying the changes in
chemical shift. NMR has also been
used to study protein folding, either
by heating the sample to the point at
which it beings to unfold or by adding
destabilizing agents and attempting to
characterize the structure of the
partially folding states.
Current limitations, and the future
Protein NMR spectroscopy does have
its limitations. It has so far been used
mainly for small proteins with
molecular weight of less than 30 kDa,
although a handful of publications
have now reported the NMR study of
proteins up to 40–50 kDa. Larger
proteins typically have faster
relaxation rates, which results in
fatter NMR peaks that tend to merge
with one another. Many structures
have now been achieved with the aid
of deuterium (2D) labelling, which
slows down spin–spin and
spin–lattice relaxation, giving sharper
peaks and better signals.
Because NMR spectroscopy
determines structure in solution, it
can only be used for proteins that are
stable in solution and do not
aggregate at concentrations of
around 1 mM. Problems have also
been encountered with the
production of isotopically enriched
proteins and also with the over-
expression and purification of
certain proteins.
NMR spectrometers with higher
magnetic fields will improve the
sensitivity and resolution of the data
obtainable. The most powerful
NMR spectrometers currently
available are 800 MHz (so-called
because that is the frequency at
which they cause a 1H nucleus to
resonate) but work is under way to
create stable 1000 MHz
spectrometers. A problem arises with
such high frequencies as we
approach the microwave region of
the electromagnetic spectrum; it
would be undesirable to ‘cook’ your
protein as you are trying to
characterize it.
As the technological side of NMR
advances, more proteins will become
accessible to the technique. It is
already obvious that the future of
protein NMR lies with the medical
or pharmaceutical applications of
knowing a protein’s structure and it
is this area that will fuel further
advances with the technique.
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